Related Experiment Video
Updated: Apr 25, 2026

12:44
Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
3.6K
Irreversible heavy chain transfer to chondroitin
Mark E Lauer1, Vincent C Hascall2, Dixy E Green3
1From the Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio 44195 and lauerm1@ccf.org.
The Journal of Biological Chemistry
|August 20, 2014
Summary
Heavy chains (HCs) transfer to chondroitin, but hyaluronan (HA) remains the preferred acceptor. Tumor necrosis factor-stimulated gene 6 (TSG-6) facilitates this irreversible HC transfer, with chondroitin acting as both reversible and irreversible acceptor sites.
Area of Science:
- Biochemistry
- Glycosaminoglycan research
Background:
- Tumor necrosis factor-stimulated gene 6 (TSG-6) mediates heavy chain (HC) transfer to hyaluronan (HA).
- HC transfer to HA is an irreversible process with no subsequent swapping between HA molecules.
Purpose of the Study:
- To investigate HC transfer to various glycosaminoglycans beyond HA.
- To characterize the kinetics and reversibility of HC transfer to chondroitin and other potential acceptors.
Main Methods:
- HC transfer experiments using TSG-6 enzyme.
- Testing chemically desulfated chondroitin, chemoenzymatically synthesized chondroitin, unsulfated heparosan, heparan sulfate, and alginate as HC acceptors.
- Kinetic analysis of HC distribution and migration on chondroitin chains.
Main Results:
- Chemically desulfated chondroitin and chemoenzymatically synthesized chondroitin accepted HCs, similar to HA.
- HCs initially distributed broadly on chondroitin but migrated to lower molecular weight chains over time.
- TSG-6 facilitates reversible HC transfer from larger to smaller chondroitin chains, creating irreversible acceptor sites.
Conclusions:
- Chondroitin serves as an HC acceptor, with TSG-6 mediating both reversible and irreversible transfer.
- While chondroitin accepts HCs, HA is the preferred acceptor when both are present.
- HCs transferred to smaller chondroitin chains or high molecular weight HA become irreversibly bound.
Related Concept Videos
Glycosaminoglycans
6.4K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
6.4K
Transcytosis of IgG
3.4K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.4K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
1.3K
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
1.3K

